The National Institutes of Health has halted its study of hydroxychloroquine, saying the drug appeared to provide 'no additional benefit compared to placebo control' for treating hospitalized COVID-19 patients.
Senate Minority Leader Chuck Schumer, D-N.Y., holds a bottle of hydroxychloroquine while raising concerns about its use.Lev Radin/Pacific Press/Pacific Press/LightRocket via Ge
Senate Minority Leader Chuck Schumer, D-N.Y., holds a bottle of hydroxychloroquine while raising concerns about its use.The National Institutes of Health has halted its study of hydroxychloroquine, a drug President Donald Trump has promoted as a possible treatment for COVID-19 and once claimed to be taking himself.issued on Saturday, the agency said that although it did not appear hydroxychloroquine caused harm to patients in the study, it was also"very unlikely to be beneficial.
"The data from this study indicate that this drug provided no additional benefit compared to placebo control for the treatment of COVID-19 in hospitalized patients," according to the NIH. The announcement could represent the final judgement in the effort to determine whether the drug can be used to treat patients hospitalized with COVID-19, an illness that has infected more than 2.2 million Americans and which has claimed
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
U.S. halts test of Trump-touted hydroxychloroquine for COVID-19 patientsUS National Institutes of Health says it has halted a clinical trial to evaluate the safety and effectiveness of the malaria drug hydroxychloroquine for the treatment of hospitalized COVID-19 patients.
続きを読む »
Novartis halts malaria drug trial against COVID-19 amid participant shortfallSwiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID-19 after struggling to find participants, it said on Friday, as data emerged from other studies raising doubts about its efficacy.
続きを読む »
US halts hydroxychloroquine clinical trial after finding no additional benefit for Covid-19 patientsThe National Institutes of Health announced Saturday that it has halted a clinical trial evaluating the safety and effectiveness of drug hydroxychloroquine as a treatment for adults hospitalized with Covid-19.
続きを読む »
Fox News poll: Biden leads Trump 50-38, COVID-19, racism, major issues - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
Sweden's hopes for herd immunity in Covid-19 fight diminishSweden has adopted a more liberal strategy during the coronavirus pandemic, keeping most schools, restaurants, bars and businesses open while much of Europe hunkered down behind closed doors.
続きを読む »
Because of COVID-19, I'm Not Sending My Son to Preschool This FallMy oldest son is precocious, extremely social, outgoing, a voracious reader, and an avid lover of learning. It almost goes without saying that he is
続きを読む »